Why is Welcure Drugs falling/rising?

As of 25-Aug, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 11.33, which reflects a decrease of 0.59 or 4.95%. The stock has underperformed its sector by 5.36% today and has been on a consecutive decline for the last two days, resulting in a total drop of 9.65% during this period. Despite having higher moving averages than the 20-day, 100-day, and 200-day averages, it is lower than the 5-day and 50-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 87.89% compared to the 5-day average. While the company has reported impressive growth in net sales and profitability over recent quarters, the low return on equity of 3.58% raises concerns about management efficiency, which may be contributing to the stock's recent downward movement.
In the broader market context, the stock's performance over the past week shows a decline of 4.31%, while the Sensex has increased by 0.45%. This indicates that Welcure Drugs is not only underperforming its sector but also lagging behind the overall market trend. Although the company has shown strong growth metrics, including a remarkable increase in net sales and profits, the current market sentiment appears to be negative, reflected in the stock's recent price movements and declining investor interest. The combination of strong financial results and poor management efficiency may be creating a complex situation for investors, leading to the stock's current decline despite its potential.